McKESSON TAGGING ONTO OUTCOMES RESEARCH: 30% STAKE ACQUIRED IN TECHNOLOGY ASSESSMENT GROUP; OUTSIDER FROM ELECTRONICS BUSINESS TO HEAD McKESSON DRUG
Executive Summary
McKesson's 30% investment in the San Francisco consulting firm, TAG (the Technology Assessment Group, Inc.), underscores the role currently being ascribed to outcomes research and cost- benefit analyses as part of full-service pharmaceutical benefit management programs.